Bioarray Genetic Diagnosis

Bioarray Genetic Diagnosis is a leading genetic testing provider based in Spain, catering to clinical partners across Europe, Latin America, MENA, and Asia. Established in 2008, the company specializes in array CGH and NGS technologies for medical genetics, reproductive genetics, and oncology-related testing. Their services include WES, WGS, expanded carrier screening, preimplantation genetic testing (PGT), and somatic and germline tests, among others. Additionally, Bioarray offers research services such as gene expression studies based on array or RNA-seq. The company's sister concern, Journey Genomics, introduced PGD-Seq™, a pioneering kit for library preparation and data analysis, designed to streamline the implementation of PGT-M in NGS labs. The company operates in the biotechnology, health care, and pharmaceutical industries and is positioned as a one-stop lab for reproductive and medical genetics. It is worth noting that there is no publicly available information on Bioarray's last investment or the involved investors. However, with its comprehensive portfolio and strategic positioning, the company presents an intriguing opportunity for potential investors seeking exposure to the rapidly evolving field of genetic diagnostics and research.